Abnormal MCH effects to HbA1c level

Written by 
Published in Biochemistry
Sunday, 23 October 2016 14:51
Rate this item
(2 votes)
Sponsored Links

Abstract

Background: Several hematological alterations are associated with altered hemoglobin A1c (Hb A1c). However, there have been no reports of their influence on the rates of exceeding standard Hb A1c thresholds by patients for whom Hb A1c determination is requested in clinical practice.

Methods: The initial data set included the first profiles (complete blood counts, Hb A1c, fasting glucose, and renal and hepatic parameters) of all adult patients for whom such a profile was requested between 2008 and 2013 inclusive. After appropriate exclusions, 21844 patients remained in the study. Linear and logistic regression models were adjusted for demographic, hematological, and biochemical variables excluded from the predictors.

Results: Mean corpuscular hemoglobin (MCH) and mean corpuscular volume (MCV) correlated negatively with Hb A1c. Fasting glucose, MCH, and age emerged as predictors of Hb A1c in a stepwise regression that discarded sex, hemoglobin, MCV, mean corpuscular hemoglobin concentration (MCHC), serum creatinine, and liver disease. Mean Hb A1c in MCH interdecile intervals fell from 6.8% (51 mmol/mol) in the lowest (≤27.5 pg) to 6.0% (43 mmol/mol) in the highest (>32.5 pg), with similar results for MCV. After adjustment for fasting glucose and other correlates of Hb A1c, a 1 pg increase in MCH reduced the odds of Hb A1c–defined dysglycemia, diabetes and poor glycemia control by 10%–14%.

Conclusions: For at least 25% of patients, low or high MCH or MCV levels are associated with increased risk of an erroneous Hb A1c–based identification of glycemia status. Although causality has not been demonstrated, these parameters should be taken into account in interpreting Hb A1c levels in clinical practice.



Sponsored Links

Additional Info

  • Author(s): Santiago Rodriguez-Segade, Javier Rodriguez Garcia, José M. García-López, Francisco Gude, Felipe F. Casanueva, Santiago RS-Alonso, Félix Camiña
  • Print ISSN: 0009-9147
  • Online ISSN: 1530-8561
  • DOI: http://dx.doi.org/10.1373/clinchem.2016.257659
  • PubMed: 27679433
  • Publisher: Clinical Chemistry
  • Copyright and Usage: © 2016 American Association for Clinical Chemistry
Last modified on Sunday, 23 October 2016 15:51
Facebook Google Plus Twitter LinkedIn

RELATED ARTICLES

Advertisement
Advertisement

Featured

CHOLERA: CAUSES, SYMPTOMS, DIAGNOSIS AND TREATMENT

CHOLERA: CAUSES, SYMPTOMS, DIAGNOSIS AND TREATMENT

CHOLERA is a specific infectious disease that affects the lower portion of the intestine and is char...

Advertisement

Useful Sites

  • NCBI

    National Center for Biotechnology Information
  • LTO

    Lab Tests Online® by AACC
  • ASCP

    American Society for Clinical Pathology
  • ASM

    American Society for Microbiology
  • The Medical Library®

    Project of BioScience.pk
Advertisement

Connect With Us

Contact Us

All comments and suggestions about this web site are very welcome and a valuable source of information for us. Thanks!

Tel: +(92) 302 970 8985-6

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Website: https://www.bioscience.pk


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Our Sponsors

InsightGadgets.comPathLabStudyTheMedicalLibrary.orgThe Physio Club

By using BioScience.pk you agree to our use of cookies to enhance your experience on this website.